New CEO of SCHWARZ PHARMA joins executive commitee of UCB
UCB appointed Detlef Thielgen, SCHWARZ PHARMA's new Chief Executive Officer, to UCB's Executive Committee effective January 1, 2007.
In his career with SCHWARZ PHARMA AG, Detlef Thielgen has held several positions in finance and controlling, including Chief Financial Officer in the USA (1995 -1999). As General Manager Operations (1999-2002), he was responsible for the worldwide production and supply chain. Since February 1, 2002, Detlef has been a member of SCHWARZ PHARMA's Executive Board as Chief Financial Officer. On December 13, 2006, Detlef was appointed Chief Executive Officer of SCHWARZ PHARMA AG effective January 1, 2007.
UCB's Executive Committee comprises also Melanie Lee, Executive Vice President R&D, Luc Missorten, Executive Vice President Chief Financial Officer, Jean-Pierre Pradier, Executive Vice President Corporate Human Resources, Bill Robinson, Executive Vice President, Global Operations, Bob Trainor, Executive Vice President, General Counsel, and is chaired by Roch Doliveux, Chief Executive Officer.
Other news from the department people
